source
- Parkinson's drug pipeline diversifies as firms seek disease-modifying therapiesSeveral pharmaceutical companies are shifting away from the traditional alpha-synuclein antibody strategy and exploring alternative mechanisms to treat Parkinson's disease. AC Immune is highlighted…
- Pharvaris reports injectable-like efficacy from once-daily oral pill for rare genetic diseasePharvaris announced that its experimental oral formulation of deucrictibant achieved efficacy comparable to injectable versions in a once-daily pill. The drug is an extended-release version intend…